AAAAAA
Results:
1-11
|
Results: 11
Authors:
BERKHOUT B
DERKSEN GCH
BACK NKT
KLAVER B
DEKRUIF CG
VISSER S
Citation: B. Berkhout et al., STRUCTURAL AND FUNCTIONAL-ANALYSIS OF NEGATIVELY CHARGED MILK-PROTEINS WITH ANTI-HIV ACTIVITY, AIDS research and human retroviruses, 13(13), 1997, pp. 1101-1107
Authors:
ESSINK BBO
BACK NKT
BERKHOUT B
Citation: Bbo. Essink et al., INCREASED POLYMERASE FIDELITY OF THE 3TC-RESISTANT VARIANTS OF HIV-1 REVERSE-TRANSCRIPTASE, Nucleic acids research, 25(16), 1997, pp. 3212-3217
Authors:
BACK NKT
BERKHOUT B
Citation: Nkt. Back et B. Berkhout, DEOXYNUCLEOSIDE TRIPHOSPHATE CONCENTRATIONS EMPHASIZE THE PROCESSIVITY DEFECT OF LAMIVUDINE-RESISTANT VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2484-2491
Authors:
KEULEN W
BACK NKT
VANWIJK A
BOUCHER CAB
BERKHOUT B
Citation: W. Keulen et al., INITIAL APPEARANCE OF THE 184ILE VARIANT IN LAMIVUDINE-TREATED PATIENTS IS CAUSED BY THE MUTATIONAL BIAS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Journal of virology, 71(4), 1997, pp. 3346-3350
Authors:
BACK NKT
NIJHUIS M
KEULEN W
BOUCHER CAB
ESSINK BBO
VANKUILENBURG ABP
VANGENNIP AH
BERKHOUT B
Citation: Nkt. Back et al., REDUCED REPLICATION OF 3TC-RESISTANT HIV-1 VARIANTS IN PRIMARY-CELLS DUE TO A PROCESSIVITY DEFECT OF THE REVERSE-TRANSCRIPTASE ENZYME, EMBO journal, 15(15), 1996, pp. 4040-4049
Authors:
BOUCHER CAB
KEULEN W
VANBOMMEL T
NIJHUIS M
DEJONG D
DEJONG MD
SCHIPPER P
BACK NKT
Citation: Cab. Boucher et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG SUSCEPTIBILITY DETERMINATIONBY USING RECOMBINANT VIRUSES GENERATED FROM PATIENT SERA TESTED IN A CELL-KILLING ASSAY, Antimicrobial agents and chemotherapy, 40(10), 1996, pp. 2404-2409
Authors:
BACK NKT
SMIT L
HOGERVORST E
VANWIJK ACWA
GOUDSMIT J
TERSMETTE M
Citation: Nkt. Back et al., DEVELOPMENT AND EVALUATION OF AN HIV-1 TRANSFECTION-NEUTRALIZATION ASSAY, Journal of acquired immune deficiency syndromes, 7(6), 1994, pp. 531-538
Authors:
ZWART G
BACK NKT
RAMAUTARSING C
VALK M
VANDERHOEK L
GOUDSMIT J
Citation: G. Zwart et al., FREQUENT AND EARLY HIV-1(MN) NEUTRALIZING CAPACITY IN SERA FROM DUTCHHIV-1 SEROCONVERTERS IS RELATED TO ANTIBODY REACTIVITY TO PEPTIDES FROM THE GP120 V3 DOMAIN, AIDS research and human retroviruses, 10(3), 1994, pp. 245-251
Authors:
BACK NKT
SMIT L
DEJONG JJ
KEULEN W
SCHUTTEN M
GOUDSMIT J
TERSMETTE M
Citation: Nkt. Back et al., AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION, Virology, 199(2), 1994, pp. 431-438
Authors:
BACK NKT
SMIT L
SCHUTTEN M
DEJONG JJ
KEULEN W
GOUDSMIT J
TERSMETTE M
Citation: Nkt. Back et al., AN N-GLYCAN WITHIN THE HIV-1 GP120 V3 LOOP IS INVOLVED IN THE MASKINGOF V3-BINDING AND CD4-BINDING NEUTRALIZATION SITES, Journal of cellular biochemistry, 1993, pp. 25-25
Authors:
BACK NKT
SMIT L
SCHUTTEN M
NARA PL
TERSMETTE M
GOUDSMIT J
Citation: Nkt. Back et al., MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES, Journal of virology, 67(11), 1993, pp. 6897-6902
Risultati:
1-11
|